MariMed Raises $23 Million Selling Convertible Preferred Stock With Warrants to London-Based Fund

MariMed Secures New Funding from Long-Term Capital Partner Capital Infusion to Strengthen Balance Sheet and Provide Funding for Strategic Acquisitions $46 Million Dollar Financing Facility to Accelerate Company Growth Strategy NORWOOD, Mass., March 2, 2021 /CNW/ – MariMed, Inc. (OTCQX: MRMD) (the “Company” or “MariMed”), a leading multi-state cannabis operator focused on health and wellness, […]